Manufacturer:

Novartis Gene Therapies

Name:

ZOLGENSMA

Category:

J Code

HCPCS:

J3399

NDC(s):

71894-0121-03, 71894-0122-03, 71894-0123-03, 71894-0124-04, 71894-0125-04, 71894-0126-04, 71894-0127-05, 71894-0128-05, 71894-0129-05, 71894-0130-06, 71894-0131-06, 71894-0132-06, 71894-0133-07, 71894-0134-07, 71894-0135-07, 71894-0136-08, 71894-0137-08, 71894-0138-08, 71894-0141-09,

Primary Type:

Gene Therapy

Route of Administration:

Intravenous

About:

ZOLGENSMA is a Gene Therapy drug manufactured by Novartis Gene Therapies and administered via the Intravenous route of administration. The J Code: J3399 is aligned to the drug ZOLGENSMA.